90238399 - KRASLOQ

Information

• Trademark
• 90238399

• Source

• Serial Number

  90238399

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 06, 2020
  4 years ago

• Transaction Date

  September 24, 2023
  a year ago

• Status Date

  February 06, 2023
  a year ago

• Published for Opposition Date

  November 09, 2021
  3 years ago

• Location Date

  January 04, 2022
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CHUO, EMILY M

• Attorney Docket Number

  MBHB 20-1657

  Attorney Name

  Eric R. Moran

  Law Office Assigned Location Code

  L10

• Owners

  • MIRATI THERAPEUTICS, INC.

Case File Statements

• GS0051: pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
• GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Case File Event Statements

• 2/6/2023 - a year ago

  23 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 2/6/2023 - a year ago

  22 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 7/2/2022 - 2 years ago

  21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/30/2022 - 2 years ago

  20 - SOU EXTENSION 1 GRANTED Type: EX1G

• 6/30/2022 - 2 years ago

  19 - SOU EXTENSION 1 FILED Type: EXT1

• 6/30/2022 - 2 years ago

  18 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/4/2022 - 3 years ago

  17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 11/9/2021 - 3 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/9/2021 - 3 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/20/2021 - 3 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/1/2021 - 3 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/10/2021 - 3 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/9/2021 - 3 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/9/2021 - 3 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/30/2021 - 3 years ago

  9 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/30/2021 - 3 years ago

  8 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/30/2021 - 3 years ago

  7 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/10/2021 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/10/2021 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/10/2021 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/4/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/20/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/9/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP